Clinical needs for transgender men in the gynecologic oncology setting

Transgender men remain at risk for gynecologic malignancies, but are an underserved population. Members of the transgender community experience discrimination and have experiences that contribute to health disparities, including in gynecology and oncology. While efforts have been made within the United States to reduce inequalities experienced by members of this community, many needs in the clinical setting remain. Increased education and training among providers and healthcare professionals, and general improvements towards understanding barriers to health screening and health resource uptake may reduce some disparities. Additional research towards screening and cancer surveillance among this community will be necessary to understand any potential additional risks and survival disparities experienced by transgender men. This review focuses on barriers and clinical needs for transgender men in the gynecologic oncology setting, and suggestions for moving forward to improve care for this patient population. •Members of the transgender community have experienced discrimination and rejection in the community and medical setting•Discriminatory experiences may lead to increased cancer-associated risk factors and decreased cancer screening•Transgender men remain at risk for gynecologic malignancies, but face barriers to adequate care•Increased provider education and outreach may improve the care for transgender men in gynecologic oncology